On October 22, Geelong released its third quarter report for 2024. In the third quarter of 2024, the company achieved revenue of 0.376 billion yuan, a decrease of 12.00% year-on-year; net income attributable to the company's shareholders was 98.3134 million yuan, a decrease of 31.11% year-on-year; net income after excluding non-recurring gains and losses was 0.104 billion yuan, a decrease of 27.73% year-on-year; basic earnings per share were 0.20 yuan per share.
新开源(300109.SZ):第三季度净利润9831.34万元,同比下降31.11%
Boai Nky Medical (300109.SZ): The net income in the third quarter was 98.3134 million yuan, a 31.11% year-on-year decrease.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.